羅平鋅電(002114.SZ):擬向銀行申請不超6.7億元綜合授信額度
格隆匯3月26日丨羅平鋅電(002114.SZ)公佈,公司於2021年3月25日召開了第七屆董事會2021年第一次定期會議,審議通過了關於《2021年度向銀行申請融資綜合授信》的預案。為滿足公司2021年度日常生產經營和業務發展的資金需求,公司及下屬公司(包含納入公司合併報表範圍的各級子公司)擬向銀行申請不超過等值人民幣6.7億元的綜合授信額度,綜合授信內容包括但不限於流動資金貸款、項目貸款、銀行承兑匯票、保函、保理、開立信用證、押匯、貿易融資、票據貼現、融資租賃等綜合授信業務。銀行授信的抵押、擔保的方式包括:礦權、不動產、機器設備的抵押,股權、知識產權、貨幣資金的質押等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.